Enhancing GABAergic Tonic Inhibition Reduces Seizure-Like Activity in the Neonatal Mouse Hippocampus and Neocortex

G T Liddiard1,2, P S Suryavanshi1, J Glykys3,2,4

  • 1Stead Family Department of Pediatrics, Iowa Neuroscience Institute, The University of Iowa, Iowa City 52242, Iowa.

Insights

Enhancing tonic inhibition with THIP (gaboxadol) reduces neonatal seizure-like activity by decreasing neuronal firing. This suggests augmenting tonic inhibition is a potential treatment for neonatal seizures.

Area of Science:

  • Neuroscience
  • Epilepsy Research
  • Neonatal Neurology

Background:

  • Neonatal seizures are often resistant to standard anticonvulsants like phenobarbital.
  • The role of tonic inhibition in neonatal seizure activity is not well understood, especially when GABA is depolarizing.

Purpose of the Study:

  • To investigate if enhancing tonic inhibition using THIP (gaboxadol) can decrease seizure-like activity in neonatal mice.
  • To determine the effects of THIP on neuronal excitability and GABAergic conductances in the neonatal brain.

Main Methods:

  • Utilized acute brain slices from neonatal C57BL/6J mice (postnatal day P5-8).
  • Employed whole-cell patch-clamp recordings to measure GABAergic tonic inhibitory conductances and neuronal excitability.
  • Used two-photon calcium imaging to assess neuronal firing.
  • Induced pharmacoresistant seizures using 4-aminopyridine and low-Mg2+ models.

Main Results:

  • THIP, a selective GABAAR agonist, enhanced tonic inhibitory conductances in neocortical and CA1 pyramidal neurons.
  • Increased neuronal rheobase and decreased neuronal firing were observed with THIP administration.
  • THIP dose-dependently reduced epileptiform activity in both neonatal and adult brain slices.

Conclusions:

  • Neonatal neocortical and CA1 pyramidal neurons possess tonic inhibitory conductances.
  • Enhancing these tonic conductances with THIP reduces neuronal firing and seizure-like activity.
  • Augmenting tonic inhibition represents a promising therapeutic strategy for neonatal seizures.